about
Measurement properties of quality of life measurement instruments for infants, children and adolescents with eczema: protocol for a systematic reviewManagement options for patients with aspirin and nonsteroidal antiinflammatory drug sensitivityVincristine and corticosteroids as first-line treatment of Kasabach-Merritt syndrome in kaposiform hemangioendothelioma.Histopathologic Features of Cutaneous Acute Graft-Versus-Host Disease in T-Cell-Depleted Peripheral Blood Stem Cell Transplant Recipients.Atopic dermatitis (eczema) in US female nurses: lifestyle risk factors and atopic comorbidities.Drug-induced photosensitivity: culprit drugs, management and prevention.Risk of rash with the anti-HER2 dimerization antibody pertuzumab: a meta-analysis.Narrowband UVB as an effective substitute for psoralen plus UVA: lessons from a psoralen shortage.Rash with the multitargeted kinase inhibitors nilotinib and dasatinib: meta-analysis and clinical characterization.Measurement properties of adult quality-of-life measurement instruments for eczema: a systematic review.Atopic dermatitis and risk of hypertension, type-2 diabetes, myocardial infarction and stroke in a cross-sectional analysis from the Canadian Partnership for Tomorrow Project.Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement.Major trauma in pregnant women during the summer.Loss of Work Productivity and Quality of Life in Patients With Autoimmune Bullous Dermatoses.Understanding common but understudied diseases in dermatology.Treating moderate-to-severe atopic dermatitis: what do dermatologists do with limited evidence?Initial validation of the Burden of Disease in Atopic Eczema instrument, a quality of life measure for adult atopic dermatitis.A case of familial paraganglioma syndrome type 4 caused by a mutation in the SDHB gene.Teaching dermatology to internal medicine residents: needs assessment survey and possible directions.Network meta-analyses of systemic treatments for psoriasis: a critical appraisalSystemic immunomodulatory treatments for atopic dermatitis: protocol for a systematic review with network meta-analysisEczema and subsequent suicide: a matched case-control studyRevisiting atopic dermatitis and cardiovascular diseaseQuality of reporting in systematic reviews published in dermatology journalsDiagnosis validation and clinical characterization of atopic dermatitis in Nurses' Health Study 2
P50
Q28078864-A6D87B96-48D0-4268-8711-EA83AE97F7BDQ28217965-E6D7F21A-A59A-4C15-A089-19C90A70C9CAQ33384439-195AFD50-191F-4C89-9DE4-8BDE04AD2908Q37139105-96062DDF-026C-485E-A1AB-D0632198DC80Q37152110-48B15EB9-23BE-4BB6-9220-34A8E491F5F4Q37924276-B371B6F0-4FAA-48B0-BA4C-ED5B330D7D46Q38025317-024FA766-9A65-4E3C-832D-6F2B10EE2DD7Q38042739-A3C7DD73-5BF5-4CE9-8D6D-7AE2A243FDD0Q38067464-9D509F0E-5FAE-4536-8D0A-821519B1A593Q38632265-7C5DCBC1-8E48-4132-A496-723D11578AB8Q38724300-79039862-0798-460E-8A0E-9B12EFD1D35FQ39150394-64C62582-2F3B-439B-BF67-5B476776A605Q46647002-3C7B687A-F726-4920-8E7C-CD7B671FC987Q47569970-7157DD72-BDBD-425C-8E14-29DC70E88913Q48193003-4B485AD1-239B-4BD6-BD48-D68FC8919A64Q48328932-6F52409D-4A02-4C3B-BD49-1CFE011CB58DQ49583795-3916CE94-72A1-42B8-A63E-296AB0AE98C6Q50793646-60912141-E0F8-4717-98E6-B07BF23175FCQ50875875-254AF48D-BC67-43F4-B9CA-22D4163319E1Q57801574-73E9C040-86A5-41F4-A85E-277026AFB781Q58694533-4443CFDE-1376-4199-8FC0-592996680F26Q59811897-C9ECD590-1F6F-401F-A59D-550C9353920DQ89149485-0286CA1F-C3CF-4CCB-A171-CAAD50C7017DQ90141611-11CFBEDC-7003-4807-B4CF-30789EC845D0Q93368156-B9E919FE-1041-4F1F-9041-09D2D23C395D
P50
description
researcher ORCID ID = 0000-0002-7388-9475
@en
wetenschapper
@nl
name
Aaron M Drucker
@ast
Aaron M Drucker
@en
Aaron M Drucker
@nl
type
label
Aaron M Drucker
@ast
Aaron M Drucker
@en
Aaron M Drucker
@nl
prefLabel
Aaron M Drucker
@ast
Aaron M Drucker
@en
Aaron M Drucker
@nl
P108
P21
P31
P496
0000-0002-7388-9475